Artificial Intelligence Diagnostics Market

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist’s time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist’s analysis, thereby improving patient care delivery.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

• Global Artificial Intelligence Diagnostics Market, By Component:
  • Software
  • Hardware
  • Services
• Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Neurology
  • Others
• Global Artificial Intelligence Diagnostics Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Vuno Inc.
  • CHC Healthcare Group
  • Aidoc
  • Imbio
  • Alivecor Inc.
  • Digital Diagnostics
  • Retina AI
  • Canon Medical Systems USA
  • Healthy IO
  • Milliman Inc.
  • GE Healthcare
  • Arterys
  • Alivecor Inc.
  • Riverain
  • Lucid Health
  • AI
  • Cardiologs